Cas:1184915-33-0 6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine manufacturer & supplier

We serve Chemical Name:6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine CAS:1184915-33-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine

Chemical Name:6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine
CAS.NO:1184915-33-0
Synonyms:s14-0802
Molecular Formula:C5H4BrN5
Molecular Weight:214.02300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:69.83000
Exact Mass:212.96500
LogP:0.39910

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like s14-0802 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,s14-0802 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,s14-0802 Use and application,s14-0802 technical grade,usp/ep/jp grade.


Related News: You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine manufacturer The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine supplier The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. 6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine vendor The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 6-bromo-[1,2,4]triazolo[1,5-a]pyrazin-2-amine factory The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.